Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Short-term Investments (2019 - 2025)

Immunocore Holdings' Short-term Investments history spans 2 years, with the latest figure at $396.4 million for Q4 2025.

  • For Q4 2025, Short-term Investments rose 8.71% year-over-year to $396.4 million; the TTM value through Dec 2025 reached $396.4 million, up 8.71%, while the annual FY2025 figure was $396.4 million, 8.71% up from the prior year.
  • Short-term Investments for Q4 2025 was $396.4 million at Immunocore Holdings, up from $393.9 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $396.4 million in Q4 2025 and bottomed at $354.6 million in Q2 2024.